INTEGRA LIFESCIENCES HOLDING (IART) Stock Analyst Ratings
USA - NASDAQ:IART - US4579852082 - Common Stock
12.01 USD
+0.2 (+1.69%)
12.01 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 54% to IART. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.34. This target is 44.38% above the current price.
IART was analyzed by 17 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about IART.
In the previous month the buy percentage consensus was at a similar level.
IART was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-31 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-10-31 | Citigroup | Maintains | Sell -> Sell |
| 2025-10-15 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-07 | Citigroup | Maintains | Sell -> Sell |
| 2025-05-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-05-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-06 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-04-11 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-31 | Argus Research | Upgrade | Hold -> Buy |
| 2025-02-26 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-05 | Citigroup | Maintains | Sell -> Sell |
| 2024-10-14 | Truist Securities | Maintains | Hold -> Hold |
| 2024-10-07 | BTIG | Upgrade | Sell -> Neutral |
| 2024-10-07 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-10-01 | Citigroup | Maintains | Sell -> Sell |
| 2024-08-28 | BTIG | Maintains | Sell -> Sell |
| 2024-08-22 | Citigroup | Maintains | Sell -> Sell |
| 2024-07-30 | BTIG | Downgrade | Neutral -> Sell |
| 2024-07-30 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-30 | Truist Securities | Maintains | Hold -> Hold |
| 2024-07-30 | Citigroup | Downgrade | Neutral -> Sell |
| 2024-07-16 | Truist Securities | Maintains | Hold -> Hold |
| 2024-07-15 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-07-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-05-22 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-05-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-07 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-05-07 | Truist Securities | Maintains | Hold -> Hold |
| 2024-05-07 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-05-07 | Morgan Stanley | Maintains | Underweight -> Underweight |
INTEGRA LIFESCIENCES HOLDING / IART FAQ
What do analysts expect the price target to be for INTEGRA LIFESCIENCES HOLDING (IART)?
17 analysts have analysed IART and the average price target is 17.34 USD. This implies a price increase of 44.38% is expected in the next year compared to the current price of 12.01.
How do analysts rate INTEGRA LIFESCIENCES HOLDING (IART)?
The consensus rating for INTEGRA LIFESCIENCES HOLDING (IART) is 54.1176 / 100 . This indicates that analysts generally have a neutral outlook on the stock.